Abbott Files New Simcor Patent Suit Against Teva
Abbott Laboratories launched another patent infringement suit in Delaware on Monday against generic-drug maker Teva Pharmaceutical Industries Ltd. in an effort to protect the market for cholesterol treatment Simcor....To view the full article, register now.
Already a subscriber? Click here to view full article